Reintjes R, Baumeister H-G, Coulombier D. Infectious disease surveillance in North Rhine-Westphalia: first steps in the development of an early warning system. Int J Hyg Environ Health 2001;203:195–199.


Rotz LD, Koo D, O’Carroll PW, Kellogg RB, Sage MJ, Lillibridge SR. Bioterrorism preparedness: planning for the future. J Pub Health Manage Prac 2000;6:45–49.

Slater PE, Costin C. Infectious disease and mortality surveillance in Israel in peace and war. Pub Health Rev 1992;93:280–284.

Stern L, Lightfoot D. Automated outbreak detection: a quantitative retrospective analysis. Epidemiol Infect 1999;122:103–110.

Talan DA, Moran GJ, Mower WR, Newdow M, Ong S, Slutsker L, Jarvis WR, Conn LA, Pinner RW. EMERGEncy ID NET: an emergency department-based emerging infections sentinel network. Ann Emerg Med 1998;32:703–711.

Stanford Report. New device helps track symptoms. October 31, 2001. Accessed at on December 21, 2001.

Toubiana L, Flahault A. A space-time criterion for early detection of epidemics of influenza-like illness. Eur J Epidemiol 1998:14:465–470.

Tsui F-C, Wagner MM, Dato V, Chang C-CH. Value of ICD-9-coded chief complaints for detection of epidemics. Proc AMIA Symp 2001:711–715 (in press).

Wagner MM, Aryel R, Dato VM, Krenzelok E, Fapohunda A, Sharma R. Availability and comparative value of data elements required for an effective bioterrorism detection system. 119 pages. Report commissioned by AHRQ. November 28, 2001a.

Wagner MM, Tsui F-C, Espino JU, Dato VM, Sittig DF, Caruana RA, McGinnis LF, Deerfield DW , Druzdzen MJ, Fridsma DB. The emerging science of very early detection of disease outbreaks. J Pub Health Manage Prac 2001b;7:50–58.

Woodall J. Official versus unofficial outbreak reporting through the Internet. Inter J Med Inform 1997;47:31–34.

Woodall JP. Global surveillance of emerging diseases: the ProMED-mail perspective. Cad Saude Publica 2001;1(Supplement):147–154.

Zelicoff A, Brillman J, Forsland DW, George JE, Zink S, Koenig S, Staab T, Simpson G, Umland E, Bersell K. The rapid syndrome validation project (RSVP). Proc AMIA Symp 2001;771–776.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement